The new organisation combines ERBI’s 350+ members with LBN’s network of over 400 organisations across a wide range of life science industry sectors. The network represents a powerhouse of commercial, clinical and academic interests with at least 60% of the UK’s life science industry base, four of the UK’s five Academic Health Science Centres and three of the world’s top six universities. The merger recognises that the Cambridge-London network is an international life science "super cluster”.
The newly merged organisation continues to have offices in both Cambridge and London, with Harriet Fear as CEO. Tony Jones becomes Director, Business Development and a member of the senior management team. Meetings and events will continue in both London and Cambridge.
